Size, Structure Help Poziotinib Pose Threat to Deadly Exon 20 Lung Cancer
A new study published in the journal Nature Medicine reports that a drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented by a previously untreatable form of the disease.